Figure 1 (Lumizyme 01)
Lumizyme Injection, Powder, For Solution
Product Images NDC 58468-0160
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lumizyme (NDC 58468-0160). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Genzyme Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2 (Lumizyme 02)
Lumizyme-figure-3 (Lumizyme 03)
Lumizyme is a medication created by Genzyme Corporation, containing 52.5 mg of alglucosidase alfa, 210 mg of mannitol, and other ingredients. The solution is meant for intravenous infusion only and should be stored refrigerated between 2°C and 8°C. The package contains a single-dose vial with no preservatives. The medication is used for the treatment of Pompe disease. The text also includes the NDC and package information, dosage and administration instructions, and the manufacturer's contact details.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
